Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Sell
15,759
-13,842
-47% -$306K ﹤0.01% 1351
2026
Q1
$690K Buy
29,601
+3,335
+13% +$104K ﹤0.01% 880
2025
Q4
$1.16M Sell
26,266
-1,912
-7% -$107K 0.01% 652
2025
Q3
$2.06M Buy
28,178
+1,064
+4% +$69.4K 0.02% 540
2025
Q2
$1.66M Buy
27,114
+11,060
+69% +$617K 0.01% 573
2025
Q1
$932K Buy
16,054
+747
+5% +$47.2K 0.01% 719
2024
Q4
$817K Buy
15,307
+1,291
+9% +$63.2K 0.01% 793
2024
Q3
$611K Sell
14,016
-9
-0.1% -$300 0.01% 874
2024
Q2
$392K Sell
14,025
-4,410
-24% -$116K ﹤0.01% 977
2024
Q1
$496K Sell
18,435
-1,192
-6% -$34K 0.01% 945
2023
Q4
$550K Buy
19,627
+105
+0.5% +$2.48K 0.01% 902
2023
Q3
$414K Buy
19,522
+508
+3% +$13.9K 0.01% 957
2023
Q2
$647K Buy
19,014
+9,652
+103% +$321K 0.01% 808
2023
Q1
$303K Buy
9,362
+482
+5% +$16K ﹤0.01% 1041
2022
Q4
$298K Buy
8,880
+1,697
+24% +$51.8K ﹤0.01% 1037
2022
Q3
$217K Buy
7,183
+1,076
+18% +$39.4K ﹤0.01% 1074
2022
Q2
$213K Buy
+6,107
New +$240K ﹤0.01% 1081

Other funds holding DOCS

Xponance's DOCS Position: Q2 2026 in Review

Xponance reduced its Doximity (DOCS) stake by 47% in Q2 2026, selling an estimated $306K and leaving 15,759 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Xponance first reported a position in DOCS in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.06M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Xponance held 15,759 shares of Doximity worth $327K as of Q2 2026.
  • Xponance sold 13,842 Doximity shares in Q2 2026, an estimated $306K.
  • Doximity made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1351 holding.
  • Xponance first reported a position in Doximity in Q2 2022 and has held it in 17 quarters since.
  • Xponance's Doximity position peaked at $2.06M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.